Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Boston Scientific (BSX) PT Raised to $26 at Oppenheimer Following Solid 4Q
February 3, 2017 9:47 AM ESTOppenheimer raised its price target on Boston Scientific (NYSE: BSX) to $26.00 (from $25.00) while maintaining a Perform rating following the company's 4Q report.
Analyst Steven Lichtman commented, "BSX delivered strong, broad-based sales growth in 4Q16 and continued solid operating margin expansion. Sales in the quarter... More
Boston Scientific (BSX) Tops Q4 EPS by 1c
February 2, 2017 6:31 AM ESTBoston Scientific (NYSE: BSX) reported Q4 EPS of $0.30, $0.01 better than the analyst estimate of $0.29. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.16 billion.
"Boston Scientific delivered excellent financial results in 2016, with accelerated revenue growth, improved profitability, and... More
